WNT1 and neoplasm: Herein, we report that, regardless of body size phenotype, the first palpable tumor appeared 57% earlier for Wnt-1 p53+/− than Wnt-1 p53+/+ tumors, consistent with the tumor-enhancing effects of decreased p53 gene dosage.